Clinical Trials Using Liposomal Rhenium Re 186

Clinical trials are research studies that involve people. The clinical trials on this list are studying Liposomal Rhenium Re 186. All trials on the list are supported by NCI.

NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.

Trial 1 of 1
  • Liposomal Rhenium Re 186 in Treating Patients with Recurrent Glioma

    This phase I / II trial studies the side effects and best dose of liposomal rhenium Re 186 and to see how well it works in treating patients with glioma that has come back (recurrent). Liposomal rhenium Re 186 consists of radioactive Re 186 placed inside of a nanoliposome. The nanoliposomes help carry radiation directly to tumor cells and not harm normal cells. The radioisotope releases radiation, which may directly kill tumor cells.
    Location: University of Texas Health Science Center at San Antonio, San Antonio, Texas